AMLo Biosciences

Biotechnology Research • Newcastle upon Tyne, England, United Kingdom • 21-50 Employees

Company overview

Headquarters	The Biosphere, Newcastle Helix, Drayman's Way, Newcastle upon Tyne, Northumberland NE4 5BX, GB
Website	amlo-biosciences.com
NAICS	541714
Keywords	Biomarkers, Skin Cancer, Melanoma
Founded	2017
Employees	21-50

Key Contacts at AMLo Biosciences

David Macdonald

Non Executive Director

Marie Labus

Chief Executive Officer

AMLo Biosciences Email Formats

AMLo Biosciences uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@abingdonhealth.com), used 50% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@abingdonhealth.com	50%
{first name}{last name}	johndoe@abingdonhealth.com	50%

About AMLo Biosciences

Formed in late 2017, AMLo Biosciences is dedicated to providing a prognostic test for early AJCC Stage I and Stage II melanoma to better identify patients’ true risk of disease progression. Those patients who are genuinely at low-risk of disease spread can be provided reassurance and better-informed follow-up care, while those identified at risk of metastasis are enabled to receive timely treatment. The test under development – AMBLor® – will be simple to use and fits seamlessly into current diagnostic practice. AMLo Biosciences has been founded by a team with an internationally acclaimed research track record in the melanoma field, through identification of translational biomarkers, drug discovery & development and the building of biotech companies.

AMLo Biosciences revenue & valuation

Annual revenue	$1,796,655
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,800,000
Total funding	$5,200,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

C-Suite

Director

Entry

Employees by Department

AMLo Biosciences has 3 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore AMLo Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-05-21	1	$3,200,000
2025-01-03	1	$2,000,000

Funding Insights

$5,200,000

Total funding amount

$2,000,000

Most recent funding amount

Number of funding rounds

AMLo Biosciences Tech Stack

Discover the technologies and tools that power AMLo Biosciences's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Underscore.js

JavaScript libraries

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Apache HTTP Server

Web servers

MonsterInsights

Analytics

jQuery

JavaScript libraries

PHP

Programming languages

Frequently asked questions

AMLo Biosciences is located in Newcastle upon Tyne, England, GB.

AMLo Biosciences was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

AMLo Biosciences has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

AMLo Biosciences has raised a total of $5,200,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at AMLo Biosciences

David Macdonald

Non Executive Director

Marie Labus

Chief Executive Officer

4.8

40,000 users